Abstract
Fluoroquinolones such as ciprofloxacin and ofloxacin became the favoured drugs for the treatment of enteric fever in many regions following the emergence of organisms with multidrug resistance (to chloramphenicol, amoxicillin, and co-trimoxazole) in the early 1990s. Although fluoroquinolones were generally superior to cephalosporins such as ceftriaxone and cefixime, the spread of organisms with decreased susceptibility to ciprofloxacin or resistance to nalidixic acid and has limited there effectiveness
| Original language | English |
|---|---|
| Pages (from-to) | 419-421 |
| Number of pages | 3 |
| Journal | The Lancet Infectious Diseases |
| Volume | 11 |
| Issue number | 6 |
| DOIs |
|
| Publication status | Published - 1 Jun 2011 |